FR2158444B1 - - Google Patents
Info
- Publication number
- FR2158444B1 FR2158444B1 FR7238764A FR7238764A FR2158444B1 FR 2158444 B1 FR2158444 B1 FR 2158444B1 FR 7238764 A FR7238764 A FR 7238764A FR 7238764 A FR7238764 A FR 7238764A FR 2158444 B1 FR2158444 B1 FR 2158444B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19492271A | 1971-11-02 | 1971-11-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2158444A1 FR2158444A1 (enExample) | 1973-06-15 |
| FR2158444B1 true FR2158444B1 (enExample) | 1975-10-31 |
Family
ID=22719403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7238764A Expired FR2158444B1 (enExample) | 1971-11-02 | 1972-11-02 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3725417A (enExample) |
| JP (1) | JPS5653536B2 (enExample) |
| BE (1) | BE790859A (enExample) |
| DE (1) | DE2253748A1 (enExample) |
| FR (1) | FR2158444B1 (enExample) |
| GB (1) | GB1380095A (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1476633A (en) * | 1973-10-03 | 1977-06-16 | Unilever Ltd | Dentifrice composition |
| DE2639935A1 (de) * | 1976-09-04 | 1978-03-09 | Hoechst Ag | Benzoesaeuren und verfahren zu ihrer herstellung |
| JPS6058224B2 (ja) * | 1978-07-31 | 1985-12-19 | 旭化成株式会社 | メトクロプラミドの製造方法 |
| US6525078B1 (en) | 2002-06-25 | 2003-02-25 | Cesare Casagrande | Compound for the treatment of atherosclerotic-thrombotic pathological conditions |
| TW200520745A (en) * | 2003-09-19 | 2005-07-01 | Chugai Pharmaceutical Co Ltd | Novel 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors |
| MY144232A (en) * | 2004-07-26 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | 5-substituted-2-phenylamino benzamides as mek inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3268526A (en) * | 1962-09-12 | 1966-08-23 | Monsanto Co | Heterocyclic polyhalobenzamide derivatives |
-
0
- BE BE790859D patent/BE790859A/xx not_active IP Right Cessation
-
1971
- 1971-11-02 US US00194922A patent/US3725417A/en not_active Expired - Lifetime
-
1972
- 1972-10-30 GB GB4999972A patent/GB1380095A/en not_active Expired
- 1972-11-02 DE DE2253748A patent/DE2253748A1/de active Pending
- 1972-11-02 JP JP10955672A patent/JPS5653536B2/ja not_active Expired
- 1972-11-02 FR FR7238764A patent/FR2158444B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE790859A (fr) | 1973-04-30 |
| US3725417A (en) | 1973-04-03 |
| DE2253748A1 (de) | 1973-05-30 |
| FR2158444A1 (enExample) | 1973-06-15 |
| GB1380095A (en) | 1975-01-08 |
| JPS5653536B2 (enExample) | 1981-12-19 |
| JPS4861448A (enExample) | 1973-08-28 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |